^
GATA6 underexpression
Pancreatic Ductal Adenocarcinoma
KRAS mutation
Pancreatic Ductal Adenocarcinoma
PD-L1 expression
Pancreatic Ductal Adenocarcinoma
No biomarker
Pancreatic Ductal Adenocarcinoma
No biomarker
Pancreatic Ductal Adenocarcinoma
No biomarker
Pancreatic Ductal Adenocarcinoma
CCL11 overexpression
Pancreatic Ductal Adenocarcinoma
No biomarker
Pancreatic Ductal Adenocarcinoma
BRCA2 mutation
Pancreatic Ductal Adenocarcinoma
ATM mutation
Pancreatic Ductal Adenocarcinoma
BRCA1 mutation
Pancreatic Ductal Adenocarcinoma
HGF-H
Pancreatic Ductal Adenocarcinoma
MSI-L/dMMR
Pancreatic Ductal Adenocarcinoma
MSI-L/dMMR
Pancreatic Ductal Adenocarcinoma
MSI-L/dMMR
Pancreatic Ductal Adenocarcinoma
PALB2 mutation
Pancreatic Ductal Adenocarcinoma
BRCA1 mutation + BRCA2 mutation
Pancreatic Ductal Adenocarcinoma
FANCF mutation
Pancreatic Ductal Adenocarcinoma
MSH2 mutation
Pancreatic Ductal Adenocarcinoma
BRCA2 mutation
Pancreatic Ductal Adenocarcinoma
BRCA1 mutation
Pancreatic Ductal Adenocarcinoma
DDR
Pancreatic Ductal Adenocarcinoma
C3M/PRO-C3 ratio elevation
Pancreatic Ductal Adenocarcinoma
PALB2 mutation
Pancreatic Ductal Adenocarcinoma
BRCA2 mutation
Pancreatic Ductal Adenocarcinoma
BRCA1 mutation
Pancreatic Ductal Adenocarcinoma
GATA6 underexpression
Pancreatic Ductal Adenocarcinoma
GATA6 underexpression
Pancreatic Ductal Adenocarcinoma
GATA6 expression
Pancreatic Ductal Adenocarcinoma
LAMC2 overexpression
Pancreatic Ductal Adenocarcinoma
ATM mutation
Pancreatic Ductal Adenocarcinoma
ARID1A mutation
Pancreatic Ductal Adenocarcinoma
ATP1B1-NRG1 fusion
Pancreatic Ductal Adenocarcinoma
APP-NRG1 fusion
Pancreatic Ductal Adenocarcinoma
FGFR1 T141R
Pancreatic Ductal Adenocarcinoma
FGFR1 T141R
Pancreatic Ductal Adenocarcinoma
PPFIBP1-ALK translocation + ALK G1202R + ALK V1180L
Pancreatic Ductal Adenocarcinoma
PPFIBP1-ALK translocation + ALK G1202R + ALK V1180L
Pancreatic Ductal Adenocarcinoma
PPFIBP1-ALK translocation + ALK G1202R + ALK V1180L
Pancreatic Ductal Adenocarcinoma
MSI-H/dMMR + TMB-H + PD-L1 overexpression
Pancreatic Ductal Adenocarcinoma
TLE2 overexpression
Pancreatic Ductal Adenocarcinoma
KRAS mutation
Pancreatic Ductal Adenocarcinoma
ANIB1 overexpression
Pancreatic Ductal Adenocarcinoma
ANIB1 overexpression
Pancreatic Ductal Adenocarcinoma
ANIB1 overexpression
Pancreatic Ductal Adenocarcinoma
ANIB1 overexpression
Pancreatic Ductal Adenocarcinoma
ANIB1 overexpression
Pancreatic Ductal Adenocarcinoma
ASS1 underexpression
Pancreatic Ductal Adenocarcinoma
TMB-L
Pancreatic Ductal Adenocarcinoma
MUC1 overexpression
Pancreatic Ductal Adenocarcinoma
TP53 mutation
Pancreatic Ductal Adenocarcinoma
DDX5 overexpression
Pancreatic Ductal Adenocarcinoma
GLI1 expression
Pancreatic Ductal Adenocarcinoma
SIRT1 overexpression
Pancreatic Ductal Adenocarcinoma
BRCA mutation
Pancreatic Ductal Adenocarcinoma
KRAS G12D + Chr del(9)(p21)
Pancreatic Ductal Adenocarcinoma
CD276 expression
Pancreatic Ductal Adenocarcinoma
SLC3A2-NRG1 fusion
Pancreatic Ductal Adenocarcinoma
ATP1B1-NRG1 fusion
Pancreatic Ductal Adenocarcinoma
KRAS G12C
Pancreatic Ductal Adenocarcinoma
KRAS G12C
Pancreatic Ductal Adenocarcinoma